| __timestamp | Halozyme Therapeutics, Inc. | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 52602000 | 27632226 |
| Thursday, January 1, 2015 | 105812000 | 97707000 |
| Friday, January 1, 2016 | 113485000 | 129037000 |
| Sunday, January 1, 2017 | 285461000 | 151332000 |
| Monday, January 1, 2018 | 141726000 | 158719000 |
| Tuesday, January 1, 2019 | 150446000 | 170104000 |
| Wednesday, January 1, 2020 | 224227000 | 192195000 |
| Friday, January 1, 2021 | 361897000 | 220706000 |
| Saturday, January 1, 2022 | 520812000 | 204426000 |
| Sunday, January 1, 2023 | 636892000 | 133788000 |
| Monday, January 1, 2024 | 855907000 |
In pursuit of knowledge
In the dynamic world of biotechnology, financial performance is a key indicator of a company's health and potential. Over the past decade, Halozyme Therapeutics, Inc. and Travere Therapeutics, Inc. have shown distinct trajectories in their gross profit margins. From 2014 to 2023, Halozyme's gross profit surged by over 1,100%, peaking in 2023, while Travere's growth was more modest, with a 384% increase, reaching its highest in 2021. This stark contrast highlights Halozyme's aggressive growth strategy and market adaptation. Notably, Halozyme's gross profit in 2023 was nearly five times that of Travere's, underscoring its dominant market position. As the biotech sector continues to evolve, these trends offer valuable insights into the strategic maneuvers of leading companies. Investors and industry watchers should keep a close eye on these developments as they reflect broader market dynamics.
Gross Profit Trends Compared: Novartis AG vs Halozyme Therapeutics, Inc.
Who Generates Higher Gross Profit? Pfizer Inc. or Halozyme Therapeutics, Inc.
Gross Profit Trends Compared: Sanofi vs Halozyme Therapeutics, Inc.
Alnylam Pharmaceuticals, Inc. and Halozyme Therapeutics, Inc.: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? Genmab A/S or Travere Therapeutics, Inc.
Key Insights on Gross Profit: Dr. Reddy's Laboratories Limited vs Travere Therapeutics, Inc.
Bio-Techne Corporation and Halozyme Therapeutics, Inc.: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? Exelixis, Inc. or Travere Therapeutics, Inc.
Ascendis Pharma A/S vs Halozyme Therapeutics, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Jazz Pharmaceuticals plc and Halozyme Therapeutics, Inc.
Gross Profit Trends Compared: Halozyme Therapeutics, Inc. vs Arrowhead Pharmaceuticals, Inc.
Gross Profit Trends Compared: Alkermes plc vs Travere Therapeutics, Inc.